Company ProfilePremium

Tali Digital Ltd

Company Profile Analysis

Ticker: TD1.AX

ESOMAR 23 Corporate BadgeISO Certifications Badge
Tali Digital Ltd - Company showcase

Year Founded & Workforce

2004

13 Employees

Tali Digital Ltd logo

Tali Digital Ltd Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Tali Digital Ltd Overview

AttributeDetailSource
Legal nameTALi Digital LimitedFY26 Annual Report
StylingCompany styles itself "TALi Digital" (lower-case "i")Company announcements
Former namesAvexa Limited (to December 2016); Novita Healthcare Limited (December 2016 to 30 December 2019)MarketBeat, Biotech Daily (secondary); ASX Notice 0021.20.12
Former ASX codesNHL (Novita Healthcare)ASX Notice 0021.20.12
Incorporation date7 April 2004FY26 Annual Report ("no dividend has been paid… since its incorporation on 7 April 2004")
JurisdictionAustralia (Corporations Act 2001); tax-consolidated group with Australian subsidiariesFY25/FY26 Annual Reports
Registered office and principal place of businessSuite 1.01, 117 Camberwell Road, Hawthorn East, VIC 3123, AustraliaFY26 Annual Report
Prior officeSuite 201, 697 Burke Road, Camberwell, VIC 3124 (to FY2025)FY25 Annual Report
Telephone1300 082 013Company announcements
Investor emailinvestors@talidigital.comDatasphere announcement, 24 Aug 2026
Exchange and tickerAustralian Securities Exchange, TD1FY26 Annual Report
Secondary quotationStuttgart, UV7 (aggregator listing; no evidence of a sponsored secondary listing)TipRanks (aggregator)
ISINAU0000074221ASX Notice 0021.20.12
CUSIPNot applicable / not publicly disclosed—
Fiscal year end30 JuneFY26 Annual Report
AuditorRSM Australia Partners, Melbourne (lead partner A L Whittingham); unmodified opinion FY25 and FY26FY26 Annual Report
Share registryAutomic Registry Services, SydneyFY26 Annual Report
SolicitorBaker McKenzie, Melbourne (as listed in FY25 directory)FY25 Annual Report
Lead manager (Aug 2026 raise)62 Capital Pty Ltd (6% fee on placement)Datasphere announcement
Company secretary / outsourced CFOTim Luscombe (Bio101), appointed 5 December 2022FY26 Annual Report
SubsidiariesTALi Health Pty Ltd (100%); YCDI Education Australia Pty Ltd (100%, from 12 June 2025); Datasphere Analytics Pty Ltd (100%, from completion on or about 29 Sep–1 Oct 2026)FY26 Annual Report; Appendix 2A filings
Operating segmentsOne segment (since 1 July 2020)FY25 Annual Report, note 4(j)

The identification details supplied (Tali Digital Ltd, ASX, TD1.AX, ISIN AU0000074221, talidigital.com, Australia) match the current listed entity. No re-listing or further name change has occurred since December 2019. The entity profiled is TALi Digital Limited (ABN 53 108 150 750; ACN 108 150 750), ASX code TD1, website www.talidigital.com.

MetricValueSource and comment
Employees (aggregator)13Morningstar profile. Not confirmed in filings; likely stale.
Employee benefits and personnel expense FY2026 (AUD)452,465FY26 Annual Report
Employee benefits and personnel expense FY2025 (AUD)197,268FY25 Annual Report
Employee benefits and personnel expense FY2024 (AUD)344,994FY25 Annual Report (comparative)
YCDI acquisition"No employees are included in the transaction"FY25 Annual Report
Headcount, 3-year trend—The annual reports do not state a headcount. The business relies heavily on outsourced CFO/company secretarial (Bio101), consultants and subject-matter experts.

Market capitalisation (as at mid-October 2026)

InputValueSource
Quoted shares after 1 Oct 2026 Tranche 2 quotation112,727,470Kalkine summary of Appendix 2A, 1 Oct 2026
Datasphere consideration shares (quotation applied 1 Oct 2026)22,000,000Kalkine summary of Appendix 2A, 1 Oct 2026
Implied shares on issueapproximately 134.7 million (analyst calculation; assumes the 22M consideration shares are additional to the 112.7M)Analyst calculation
Recent pricesAUD 0.090 at 26 Aug 2026 release; AUD 0.078–0.10 range observed in Aug–Oct 2026 on aggregator pagesInvestSMART, StockLight (secondary)
52-week rangeAUD 0.04–0.15StockLight (secondary)
Estimated market capitalisationAUD 10.8M–13.5M at AUD 0.08–0.10 per share (analyst calculation)Analyst calculation

The estimate below uses filed share counts and recent observed prices.

Earlier aggregator snapshots (AUD 2.1M on Simply Wall St; AUD 3–4M on InvestSMART; €2.26M on Parqet) pre-date the August–October 2026 recapitalisation and the Datasphere issue, and are superseded.

TALi Digital is an Australian micro-cap that has migrated, in three distinct phases, from failed HIV drug developer (as Avexa), to paediatric digital-health company (TALi DETECT and TALi TRAIN attention screening and training, rooted in Monash University research), to school social-emotional learning (SEL) provider after acquiring the You Can Do It! Education (YCDI!) business in June 2025. In FY2026 YCDI! generated effectively all of the group's AUD 274,898 revenue, mainly from digital school subscriptions on a CANVAS learning-management platform, physical early-years resources and royalties. In August–October 2026 the company bolted on Datasphere Analytics, an early-stage vehicle holding an option to license memristive processing-in-memory IP from Israel's Technion. The stated intent is to turn YCDI! into an AI-assisted, sovereign-data education platform. The investment case is therefore a small, real but sub-scale SEL business plus a long-dated, unproven deep-technology option, funded by a freshly raised equity base.


Company's own description (FY2026 Annual Report, paraphrased)

The FY2026 Annual Report describes TALi as a digital health company delivering diagnostic and therapeutic solutions to enhance attention and cognitive function, built on a patented platform targeting cognitive attention skills, incorporated into the ReadyAttentionGo! training modules. These are play-based programs designed to complement existing therapy, with a vision of improving childhood cognitive performance through early intervention. ReadyAttentionGo! is being considered as a component of neurodivergent learning strategies being developed for the YCDI! programs (ages 3–18). The company's broader focus is described as "technologies that can be a platform to enhance learning".

The report then describes YCDI!, acquired June 2025, as a leading Australian SEL program. Per the company, it has reached over one million students, is aligned with the ACARA national curriculum, and is recognised by Beyond Blue's Be You initiative. It provides evidence-based programs for children aged 3–18, self-paced tertiary online courses, professional development for educators and parent micro-courses, built around five skills: confidence, persistence, organisation, getting along and resilience.

The FY2026 operating review states the overarching objective for YCDI!: to build a comprehensive, AI-assisted universal platform that enhances SEL, educational outcomes and personal development. It adds that in FY2026 the company began actively seeking strategic M&A in the AI sector.

Independent characterisation

Despite the "digital health" label, TALi is today economically an Australian K-12 and early-childhood education-services business. The digital-health heritage (TALi DETECT and TRAIN) generated no meaningful revenue in FY2024–FY2025. Its intangible assets were fully impaired in FY2024 (AUD 4.19M). The product rights were tied up in the administration of distribution partner Genius Learning (Vertical 4 Pty Ltd) from March 2025. The FY2026 revenue disaggregation contains no line identifiable as TALi DETECT/TRAIN revenue.

The Datasphere acquisition adds a third, conceptually separate element: an option on a deep-technology hardware/architecture IP licence (memristive in-memory computing). It is pre-revenue, carries Technion royalty and capital-raising conditions subsequent, and is linked to the education business mainly by a sovereign-data narrative.

Business model and revenue model

Revenue stream (FY2026)RecognitionAUD% of revenueDescription
Service revenue (subscriptions)Over time, straight-line over subscription term194,09470.6%Annual digital subscriptions to YCDI! content and learning resources via CANVAS LMS
Sale of goodsPoint in time (delivery)38,98614.2%YCDI! non-digital materials (puppets, activity books, travel bags, printed resources)
RoyaltiesAs earned41,81815.2%Royalty income. The counterparty is not identified; a portion is earned in Europe.
Total—274,898100.0%FY26 Annual Report, note 4

Percentages are analyst calculations.

Mix characterisation: about 71% subscription/SaaS-like, 14% product, 15% licensing/royalty. Deferred income rose from AUD 3,532 to AUD 189,499 over FY2026 (current-year additions AUD 380,061). This means FY2026 billings were materially above recognised revenue, a positive lead indicator for FY2027 recognised revenue if renewals hold.

Value-chain position

TALi is a content owner and platform operator. It owns YCDI! curriculum IP and brand. It licenses third-party LMS infrastructure (CANVAS), sources physical resources from suppliers, and sells direct to schools and educators. Partnerships extend reach (e.g., the Resilient Educator Partnership with an independent schools network in Victoria). In the legacy TALi business, the company owned patented software and outsourced product development, sales and support to Genius from August 2023. With Datasphere it would sit at the upstream IP-licensee layer of a semiconductor/computing-architecture value chain, initially as a research-funding vehicle.

Customer types and end-markets

Customer typeProductEvidence
Primary and secondary schools (government, Catholic, independent)YCDI! subscriptions, workshops, PDFY26 Annual Report
Early-childhood centres / early yearsPuppets, early-years programsFY26 Annual Report
Teachers and school staff (wellbeing)Resilient Educator Partnership, 21-Day Reset, Mental Health First AidAnnouncement, 23 Jul 2026
Tertiary/self-paced learnersOnline coursesFY26 Annual Report
ParentsMicro-courses, take-home resourcesFY26 Annual Report
International schools/distributorsExploratory interest in Estonia, Romania, Saudi Arabia, New Zealand, JapanFY26 Annual Report
Clinicians, NDIS participants (legacy)TALi DETECT/TRAINStockhead (2019); company materials

End-markets: Australian K-12 SEL and student wellbeing; teacher wellbeing and professional learning; early-childhood education; legacy paediatric attention screening and training; prospectively secure data processing and in-memory computing.

Strategy

Stated strategic themes (FY2026 Annual Report and 2026 announcements, paraphrased)

  1. Build YCDI! into a comprehensive, AI-assisted universal platform for SEL, educational outcomes and personal development across the whole school community.

  2. Accelerate via strategic acquisitions, including AI technologies. FY2026 added an active AI-sector M&A search.

  3. Sales growth, retention, partnerships and cross-selling, the four-pillar commercial strategy outlined in the January/February 2026 update.

  4. Digital capability and impact reporting: refine CANVAS, embed outcome measurement.

  5. Sovereign, secure data analytics. Datasphere is positioned to give TALi in-house ability to analyse sensitive student and staff data (attention and cognitive data, learning progress, wellbeing screening) without reliance on third-party infrastructure.

  6. Replicate partnership models across states: Resilient Educator in Victoria first, with intent to replicate in other states.

  7. International exploration: Estonia, Romania, Saudi Arabia, New Zealand, Japan.

Initiative register (last 24 months)

DateInitiativeTypeTargets / metrics disclosedStatus
Jun 2025YCDI! acquisitionM&A / new businessAUD 1.34M cashCompleted; fully impaired FY2026
Jun–Jul 2025Recapitalisation (placement plus entitlement)CapitalAUD 0.8M plus AUD 0.13MCompleted
FY2026YCDI! migration to CANVAS LMS; flexible subscription tiers; onboardingPlatform investment—Completed by Feb 2026
FY2026New early-years puppets, activity book, travel bagProduct—Launched
FY2026"I am THRIVING" podcast; Tuesday Thrive campaign; Term 3 sales launchMarketingEngagement metrics cited as growing (not quantified)Ongoing
Nov 2025100:1 consolidationCapital structure4.67bn to about 46.7M sharesCompleted
FY2026–27Pipeline: Neurodivergent Learning Strategies, Coaching, AI for Educators, 21-Day Reset, MHFA instructor certificationProductMHFA instructor rollout Q4 CY2026In development
23 Jul 2026Resilient Educator PartnershipPartnership / contractAt least 60 teachers initially, potential over 400 across over 250 schools; potential YCDI! revenue over AUD 0.5M by end-2027Launching Oct 2026
24 Aug 2026Datasphere acquisition and Technion optionM&A / technology betQualifying financing USD 650k; further USD 1.0M and USD 1.35M conditions; 2% royaltyCompleted about 29 Sep–1 Oct 2026; licence status unconfirmed
Aug–Sep 2026AUD 3.3M capital raising (placement AUD 2.8M plus SPP up to AUD 0.5M) with 1-for-3 AUD 0.15 five-year optionsCapitalUse of funds disclosed (see below)Completed; SPP about 4x oversubscribed
UseAUD%
Qualifying financing to Datasphere (USD 650k)920,00027.9
Datasphere due diligence, integration, commercialisation580,00017.6
Product development (existing business)650,00019.7
Product personnel (existing business)350,00010.6
Sales and marketing (existing business)200,0006.1
Working capital402,00012.2
Costs of raising198,0006.0
Total3,300,000100.0

Use of funds, August 2026 raise (company statement of intent, AUD)

Guidance and targets

TALi provides no quantitative revenue, EBITDA or medium-term financial guidance. Qualitative guidance (FY26 Annual Report): YCDI! trading income was consistent with forecasts; operating cash burn was low and in line with guidance; refreshed 2026 programs and partnership offerings are expected to support YCDI! revenue growth in H2 CY2026. The only quantified forward figure is the Resilient Educator potential of over AUD 0.5M by end-2027. The YCDI! value-in-use model assumed 15% revenue growth, an internal planning assumption, not guidance. No ESG or sustainability commitments are disclosed. No formal cost-reduction program is announced beyond prudent cost management.

Products & Services

YCDI! (You Can Do It! Education) — current revenue engine

Product / serviceDescriptionTarget customerLaunch / latest versionPricing modelSource
YCDI! Early Years programSEL curriculum for ages 3–5 built around the five "keys" (confidence, persistence, organisation, getting along, resilience); redesigned puppetsEarly-childhood centres, kindergartensPuppets redesigned 2025–26Subscription plus physical goodsFY26 Annual Report
YCDI! Primary and Secondary programsEvidence-based SEL lessons for ages 5–18, ACARA-alignedSchoolsMigrated to CANVAS LMS, completed by Feb 2026Annual digital subscription, flexible tiersFY26 Annual Report; 1HFY26 announcement
CANVAS-based digital platformVideo learning, embedded pre/post surveys, improved reporting, dedicated technical support and onboardingSchoolsCompleted FY2026Included in subscription tiersFY26 Annual Report
Bundle pathway quizWebsite tool that personalises product recommendationsSchool buyersFY2026Free (sales tool)FY26 Annual Report
"I am THRIVING" podcastPodcast integrated into CANVAS for professional learningEducatorsFY2026IncludedFY26 Annual Report
"YCDI Tuesday Thrive"Weekly re-engagement campaignSubscribersFY2026MarketingFY26 Annual Report
Puppet Activity Book and Take-Home Travel BagPhysical resources for classroom and homeEarly years, parentsFY2026Unit saleFY26 Annual Report
Tertiary self-paced online coursesProfessional and tertiary-level coursesEducators, studentsOngoingPer courseFY26 Annual Report
Parent education micro-coursesShort courses for parentsParentsOngoingPer courseFY26 Annual Report
Workshops and PDFace-to-face/online professional developmentSchoolsOngoingFee for serviceTipRanks summary of Jan 2026 update
Resilient Educator Partnership14-month teacher wellbeing program: online courses, workshops, Mental Health First Aid International certification, ICF-accredited coaching, termly resilience assessments via The Resilience Institute GlobalTeachers in an independent schools network (Victoria)Launch Oct 2026, through end-2027Program fee; potential revenue to YCDI! over AUD 0.5M by end-2027Announcement, 23 Jul 2026
Pipeline programDescriptionStatus
Neurodivergent Learning Strategies for AllSEL support for neurodivergent students; may incorporate ReadyAttentionGo!In development
YCDI Coaching ProgramLive sessions complementing digital contentIn development
AI for EducatorsTeacher skills for ethical AI useIn development
21-Day Reset for EducatorsWellbeing and resilience programIn development
Mental Health First Aid instructor certificationWhole-school staff accreditation; certified instructor rollout planned Q4 CY2026Planned
Additional ReadyAttentionGo! moduleAddresses attention difficultiesIn development (TipRanks summary, Jan 2026)

Legacy TALi digital-health products

ProductDescriptionTarget customerVersion / statusPricing modelSource
TALi DETECT®Game-based digital screening, about 20–30 minutes of cognitive tasks (described elsewhere as seven tests) that profile a child's attention against peersClinicians, schools, parentsUS reimbursement pathway reported 2019; commercial activity dormant since Genius outsourcing; rights subject to administrator engagement from Mar 2025Historically per-assessment/licence; clinician screening payment cited at about USD 36 (2019)Stoxray, Parqet, Stockhead (secondary)
TALi TRAIN®Five-week, play-based cognitive training program (ages about 3–8) targeting selective attention and numeracy, designed with Monash University neuroscientists on about 20 years of researchClinicians, NDIS participants, parentsControlled commercial launch to 108 clinicians; dormantLicence/subscription (historical)Startup Daily; Dealroom (secondary)
TALi PortalDashboard for clinicians, educators and parents to monitor daily performance and tailor the programClinicians, educators, parentsLegacyBundledParqet (secondary)
ReadyAttentionGo!Training modules on the TALi patented platform; now positioned as a component of YCDI! neurodivergent strategiesSchools via YCDI!Being re-purposed 2026To be determinedFY26 Annual Report

Datasphere / Technion technology (pre-commercial)

AssetDescriptionStatusEconomic termsSource
Option over "In-memory Computing in Emerging Memory Technologies" IP and TRDF know-howMemristive logic and memristive Memory Processing Unit (mMPU) architecture developed by Prof. Shahar Kvatinsky's group at Technion. Performs analytics inside memory rather than shuttling data to a processor.Option to negotiate exclusive licence until 3 Oct 2026, exercisable on USD 650k qualifying financing. No licence granted as at the 24 Aug 2026 announcement. Exercise/licence status after 3 Oct 2026 was not confirmed in sources reviewed.2% royalty on net sales; 20% of sublicence fees; reimburse NIS 579,177 past patent costs (15%/40%/45% over 24 months); raise further USD 1.0M within 18 months and USD 1.35M within 36 months; TRDF to receive 30% of consideration (6.6M TALi shares) and board seat while at or above 3.5%Datasphere announcement; Notice of Meeting

The company stresses the technology is early-stage, unproven at commercial scale and generates no revenue.

Financial Narrative

Data-quality note

FY2024–FY2026 income statement, balance sheet and cash flow figures are taken from the audited FY2025 and FY2026 annual reports. FY2022–FY2023 figures are partly from the five-year summaries in those reports (net loss, share price, EPS) and partly from aggregators (TipRanks, Stoxray), marked as such. FY2025 figures were restated in the FY2026 report following finalisation of YCDI! purchase-price accounting: goodwill was reallocated to customer relationships and software, and a deferred tax liability was recognised. Both original and restated values are shown where they differ.

Income statement

Notes:

  • FY2022–FY2023 operating revenue, D&A, EBITDA, EBIT and pre-tax loss are aggregator (TipRanks) and unreconciled.

  • FY2024 operating revenue is net of AUD 30,343 refunds.

  • FY2024–FY2026 EBITDA is an analyst calculation: pre-tax loss plus D&A less interest income. FY2024 interest was AUD 85,493, FY2025 AUD 54,743, FY2026 AUD 12,274.

  • FY2024 EBIT is an analyst calculation: pre-tax loss less interest income (85,493) and other income (174,575, including grants, R&D incentive release and investment sale).

  • FY2025 values are restated per the FY2026 report. Originally reported FY2025: net loss AUD -656,885; pre-tax AUD -656,885; tax nil.

Per-share data

Notes:

  • FY2026 EPS is post-consolidation as reported.

  • FY2022–FY2024 post-consolidation EPS and share counts are analyst calculations (pre-consolidation figures multiplied by 100 for EPS, divided by 100 for shares). FY2022–FY2023 weighted shares are aggregator.

  • FY2025 is restated in the FY26 report.

  • No dividend has been paid since incorporation (FY26 Annual Report).

Margins and growth

Analyst calculations. FY2024 margins are not meaningful (negative revenue) and are shown as 0. FY2025 margins are mathematically extreme because of AUD 1,186 of revenue. Revenue CAGR FY2022–FY2026 (13,165 to 274,898) is about 114% per year (analyst calculation), but this reflects a change of business through acquisition rather than organic growth and should not be extrapolated.

Balance sheet

Notes:

  • FY2023 cash is the FY2024 opening balance. FY2023 intangibles are the FY2024 opening carrying amount. FY2023 deferred income is the FY2024 opening balance. FY2023 borrowings are inferred from AUD 503,744 repaid in FY2024. FY2023 equity is the FY2024 opening balance.

  • FY2025 is restated per the FY2026 report. Originally reported FY2025: goodwill AUD 1,307,964; total assets AUD 2,658,421; total liabilities AUD 386,894; equity AUD 2,271,527.

  • FY2022 balance-sheet detail is not publicly disclosed in sources reviewed.

  • Debt split (short/long): no borrowings at 30 June 2024, 2025 or 2026. Deferred consideration payable to The Bernard Group was AUD 120,000 current at 30 June 2026 (FY2025: AUD 80,000 current plus AUD 113,424 non-current).

  • Issued capital AUD 216,081,773 against accumulated losses AUD 215,777,336 (FY2026) illustrates the scale of historic capital consumption.

  • Unused tax losses about AUD 168M, unrecognised (FY2026).

Cash flow

FY2022–FY2023 operating cash flow is aggregator (Stoxray). Capex is shown as nil where none is reported in FY2024–FY2026; for FY2022–FY2023 it is not disclosed in sources reviewed (no PP&E capex visible). FY2024 operating cash flow was flattered by a one-off AUD 666,813 R&D tax incentive receipt; underlying FY2024 burn was about AUD 1.03M (analyst calculation).

Ratios

Analyst calculations on average equity and average total assets (FY2025 restated). ROIC, net debt/EBITDA and interest coverage are not meaningful: EBITDA is negative, there is no debt and no interest expense. Cash conversion cycle is not meaningful given negligible receivables and inventory and subscription billing in advance. FY2026 receivables days are about 60 and inventory days about 300 on cost of sales (analyst calculations, low reliability at this scale).

Half-year data points

Source: 1HFY25 and 1HFY26 Appendix 4D (via TipRanks/InvestSMART summaries). The 1HFY25 "revenue" figure includes interest and other income.

Commentary on trends, inflections and drivers

Three regimes. FY2022 was the high-water mark of spend on the TALi platform (net loss AUD 6.9M, operating cash burn AUD 4.3M), funded by the 2019–2022 equity raisings. FY2023–FY2024 marked retrenchment. The August 2023 decision to outsource development, sales and support to Genius collapsed the cost base, refunded customers and triggered the FY2024 write-off of all TALi intangibles (AUD 4.19M, partly offset by a AUD 2.05M release of deferred grant/R&D income). FY2025 was a shell-like year: revenue AUD 1,186, cash burn of about AUD 0.1M a quarter, ending with the YCDI! acquisition.

FY2026 inflection. The first full year of YCDI! moved receipts from customers from nil to AUD 437,556 and recognised revenue to AUD 274,898, with an 83% gross margin. But operating costs rose too: personnel AUD 452k (from 197k), amortisation of acquired intangibles AUD 157k, professional fees AUD 346k, insurance AUD 84k. Underlying EBITDA (ex-impairment) was about AUD -0.95M versus AUD -0.71M in FY2025. The headline AUD 2.21M loss was dominated by the AUD 1.34M impairment that wrote the whole YCDI! cash-generating unit to nil roughly 12 months after purchase.

Cash runway was the binding constraint until September 2026. Cash fell from AUD 2.99M (FY2023) to AUD 0.97M (FY2026). The going-concern note relied on the AUD 3.3M raise. The SPP's heavy oversubscription (about AUD 2.0M applied against AUD 0.5M) and completion of the AUD 2.8M placement mean pro-forma cash is likely about AUD 3.5–4.0M before the AUD 0.92M qualifying-financing payment to Datasphere. That estimate assumes about AUD 3.3M gross less 6% costs plus about AUD 0.9M of opening cash net of Q1 FY2027 burn; it is an analyst estimate pending the September-quarter Appendix 4C. On FY2026 burn rates (operating about AUD 0.74M per year) that is a multi-year runway for YCDI! alone. But the Datasphere/Technion conditions (USD 1.0M within 18 months and USD 1.35M within 36 months of the licence) imply further capital needs if the licence is executed.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Group Entities

EntityOwnershipFunctionSince

TALi Digital Limited

Listed parent

Holding company, corporate, listing

2004

TALi Health Pty Ltd

100%

Holds TALi DETECT/TRAIN/ReadyAttentionGo! IP and legacy operations

—

YCDI Education Australia Pty Ltd

100%

Operates YCDI! SEL business

12 Jun 2025

Datasphere Analytics Pty Ltd (ACN 689 577 419)

100%

Holds Technion option/MOU over memristive in-memory computing IP

Completion about 29 Sep–1 Oct 2026

Business Lines

Business line (AUD)FY2024FY2025FY2026

Legacy TALi revenue net of refunds

-28,34700

YCDI! revenue

01,186274,898

Total operating revenue

-28,3471,186274,898

Revenue type (AUD)

Revenue type (AUD)FY2024FY2025FY2026

Service revenue recognised over time

1,9960194,094

Refunds

-30,34300

Sale of goods

01,18638,986

Royalties

0041,818

Total operating revenue

-28,3471,186274,898

Income Statement (AUD)

Metric (AUD)FY2022FY2023FY2024FY2025FY2026

Operating revenue

13,16526,627-28,3471,186274,898

Revenue and other income incl. interest

——231,72155,591286,744

Cost of sales

——00-46,738

Gross profit

——-28,3471,186228,160

Net impairment

——-2,144,1020-1,335,237

Depreciation and amortisation

-371,380-319,750-178,198-5,155-156,802

EBITDA (reported basis)

-7,170,000-2,540,000-3,024,336-711,628-2,281,199

EBITDA excluding impairment

——-880,234-711,628-945,962

Operating income (EBIT, excl. interest)

-7,720,000-3,030,000-3,202,534-716,445-2,437,573

Pre-tax loss

-7,550,000-2,860,000-3,117,041-662,040-2,425,727

Income tax benefit

——01,416214,068

Net loss

-6,936,129-2,258,623-3,117,041-660,624-2,211,659

Per-Share Data and Share Count (millions)

MetricFY2022FY2023FY2024FY2025FY2026

Basic EPS, as originally reported (AUD cents, pre-consolidation)

-0.69-0.11-0.09-0.02-4.83

Basic EPS, post-consolidation basis (AUD cents)

-69-11-9.46-2.00-4.83

Diluted EPS (AUD cents, post-consolidation basis)

-69-11-9.46-2.00-4.83

Dividends per share (AUD cents)

00000

Weighted average shares, post-consolidation basis (millions)

12.021.532.9533.1045.78

Margin Analysis (%)

Metric (%)FY2024FY2025FY2026

Gross margin

0100.083.0

EBITDA margin excluding impairment

0-60,002-344.1

Net margin

0-55,702-804.5

Revenue growth YoY

0023,079

Balance Sheet (AUD)

Metric (AUD)FY2023FY2024FY2025FY2026

Cash and cash equivalents

2,986,7332,122,3831,291,599973,791

Trade and other receivables

—64,54128,94344,869

Inventories

0051,71338,375

Total current assets

—2,191,8821,376,7101,081,297

Goodwill

00635,2600

Other intangibles

4,358,3890856,7790

Total assets

—2,191,8822,868,7491,081,297

Trade and other payables (current)

—41,606269,937246,435

Deferred income

2,136,25203,532189,499

Total liabilities

—41,606600,961435,934

Total debt (borrowings)

503,744000

Net debt (net cash shown negative)

-2,482,989-2,122,383-1,291,599-973,791

Total equity

5,168,5462,150,2762,267,788645,363

Working capital

—2,150,2761,103,241645,363

Cash Flow (AUD)

Metric (AUD)FY2022FY2023FY2024FY2025FY2026

Receipts from customers

——-31,1810437,556

R&D tax incentive received

——666,81300

Operating cash flow

-4,328,145-2,000,141-363,349-472,806-737,321

Capex

00000

Free cash flow

-4,328,145-2,000,141-363,349-472,806-737,321

Business acquisitions

000-1,140,000-80,000

Proceeds from share issues

——0800,000577,525

Share issue costs

——0-53,000-77,919

Repayment of borrowings

——-503,74400

Dividends paid

00000

Buybacks

00000

Net change in cash

——-867,093-830,806-317,715

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2024FY2025FY2026

ROE (%)

-85.2-29.9-151.8

ROA (%)

—-26.1-112.0

Current ratio (x)

52.75.032.48

Debt to equity (x)

000

Asset turnover (x)

—0.00050.14

Income Statement (AUD) (1HFY2025–1HFY2026)

Metric (AUD)1HFY20251HFY2026

Revenue (as reported in Appendix 4D)

36,70472,834

Loss after tax

-263,945-570,848

Region (AUD) Overview

Region (AUD)ServicesGoodsRoyaltiesTotal

Australia

172,45420,16737,181229,802

New Zealand

17,398160017,558

Europe

016,6044,63721,241

Rest of World

4,2422,05506,297

Total

194,09438,98641,818274,898

Region (AUD) Overview (Annual)

Region (AUD)FY2026

Australia

229,802

New Zealand

17,558

Europe

21,241

Rest of World

6,297

Per-Share Data

Metric (AUD per share)FY2021FY2022FY2023FY2024FY2025FY2026

FY-end price, as reported (pre-consolidation basis to FY2025)

0.0320.0060.0020.0020.0010.063

FY-end price, post-consolidation equivalent

3.200.600.200.200.100.063

Change by Horizon

Horizon (to 30 Jun 2026)Change

1-year (from AUD 0.10)

-37%

3-year (from AUD 0.20)

-69%

5-year (from AUD 3.20)

-98%

Market Index 1-year relative to ASX 200 (snapshot date unclear)

-41.42%

Valuation Multiples

MultipleTALi (analyst calculation)Comment

Market cap

AUD 10.8M–13.5M

At AUD 0.08–0.10 on about 134.7M shares

Enterprise value

About AUD 7–10M

Assuming about AUD 3.5–4.0M pro-forma cash and no debt (estimate)

EV / Sales (FY2026)

About 25–36x

Not comparable to profitable edtech

P / B

About 15–20x on FY2026 book of AUD 0.65M

Book materially higher post-raise; recalc after Dec-26 half

Securities on Issue

SecurityNumberTermsSource

Quoted ordinary shares

112,727,470—

Appendix 2A, 1 Oct 2026

Consideration shares (Datasphere)

22,000,000

Issued 1 Oct 2026 (6.6M to TRDF)

Appendix 2A, 1 Oct 2026

Unquoted options (TD1AI)

21,533,258

AUD 0.15, expire 29 Sep 2031

Appendix 2A, 1 Oct 2026

Unquoted options (FinCap)

1,250,000

AUD 0.10, expire Nov 2028

FY26 AR; Appendix 2A

Other unquoted options

1,210,516

Various (AUD 0.40–1.20; 2027–2028)

Appendix 2A, 1 Oct 2026

Share Price & Returns

DateRaisePriceAmount (AUD)Source

Jul 2017

Placement plus rights issue (Newly)

——

BioSpectrum Asia

Jul 2018

Placement

—

2.7M

Biotech Daily

25 Nov 2019

Placement

—

6.2M

InvestSMART

Mar 2022

Capital raise (broker options)

——

FY25 AR note 18

Mar 2023

Capital raise (85M broker options)

——

FY25 AR note 18

19 Jun 2025

Placement (800M shares)

0.001800,000

FY25 AR

Jul 2025

Entitlement offer (1-for-6)

0.001

About 131,388

FY25 AR

Sep–Oct 2025

Shortfall placement

0.001

About 446,000

FY26 AR (total FY26 issues AUD 577,525)

Aug–Oct 2026

Placement (56M) plus SPP (up to 10M) with 1-for-3 options

0.05

About 3.3M

Datasphere announcement; Appendix 2A

Analyst Conclusions

Management guidance

No numerical guidance. Management expects the refreshed 2026 program suite, flexible subscriptions and partnership offerings to support YCDI! revenue growth in H2 CY2026. It describes the YCDI! business as well-positioned for sustainable growth, and says it continues to assess assets to bolster the platform (FY26 Annual Report). Resilient Educator potential of over AUD 0.5M by end-2027 is the only quantified forward indicator.

Consensus

None. No analyst coverage.

Bull case

  1. The education core is inflecting from a near-zero base. FY2026 receipts of AUD 437,556 and deferred income of AUD 189,499 show billings running well ahead of recognised revenue (AUD 274,898). Adding Resilient Educator (over AUD 0.5M potential to end-2027) and the MHFA certification rollout could plausibly double revenue within two years, at an 83% gross margin.

  2. The balance sheet has been reset. About AUD 3.3M was raised against FY2026 operating burn of AUD 0.74M. Retail demand was strong (SPP about 4x covered), and there is no debt. TALi can fund YCDI! growth and the first Datasphere phase without immediate further dilution. The AUD 0.15 options could add about AUD 3.2M if the share price performs.

  3. The Technion option is cheap asymmetric exposure. For 22M shares (AUD 1.1M deemed) plus USD 650k of qualifying financing, TALi gains a pathway to an exclusive, worldwide, sublicensable licence over a recognised academic group's processing-in-memory IP, at a modest 2% royalty and 20% of sublicence fees. A single sublicensing deal with a memory or AI-hardware player could be worth multiples of the current market capitalisation.

Bear case

  1. Management's own numbers say YCDI! is worth little. The CGU was impaired to nil 12 months after purchase, on a value-in-use model that already assumed 15% revenue growth. Personnel, insurance, professional and KMP costs far exceed gross profit (AUD 228k). Listed-company overheads alone may absorb any growth.

  2. Datasphere is a pre-licence, capital-hungry science project. The option expired 3 October 2026 unless exercised. The licence carries USD 2.35M of additional raising conditions within 36 months plus patent-cost reimbursements, and the technology is explicitly unproven at commercial scale. The strategic link to a school SEL business (sovereign student-data analytics) is thin. Execution requires semiconductor expertise the board does not obviously possess.

  3. History and structure argue for caution. The entity has consumed AUD 216M of paid-in capital across three strategies (HIV drug, paediatric digital health, now SEL plus deep tech) with no sustained commercial success. Share-price performance was -98% over five years on a consolidated basis. Governance is thin (three directors, no CEO or CFO, an executive chair labelled independent). About 24M options sit over the register.

Catalysts and monitorables (next 12 months)

TimingCatalyst / monitorableWhat to watch
By 31 Oct 2026September-quarter Appendix 4CPost-raise cash; USD 650k Datasphere payment; customer receipts
Oct 2026 onwardTechnion option exercise and licence negotiationConfirmation of exercise before 3 Oct expiry; 45-day negotiation; definitive licence signing (must occur within 180 days of exercise)
Oct 2026Resilient Educator launchTeacher sign-ups against the 60 minimum and 400 potential
26 Nov 2026AGMRemuneration report vote; director elections; any TRDF board nominee
Q4 CY2026MHFA instructor certification rolloutWhole-school accreditation uptake
Jan 2027December-quarter 4CTerm 1 2027 pre-sales; deferred income
Feb 20271HFY27 Appendix 4DRevenue growth vs 1HFY26 (AUD 72.8k); Datasphere accounting (intangible or expense)
2,027Datasphere technical roadmapPrototype milestones; sublicensing discussions; USD 1.0M funding within 18 months of licence
OngoingFurther AI M&AAdditional acquisitions and dilution
OngoingGenius / Vertical 4 rights recoveryWhether TALi DETECT/TRAIN rights are recovered and re-commercialised via YCDI!

Analyst verdict

TALi Digital is best understood not as a digital-health company but as a recapitalised listed shell. It contains two assets of very different character: a small, genuine, high-gross-margin school SEL franchise (YCDI!) and a speculative option on Technion processing-in-memory IP (Datasphere).

The audited record is unflattering. FY2026 revenue of AUD 274,898 against a AUD 2.21M loss. A full impairment of the AUD 1.34M YCDI! acquisition within a year. Rising operating cash burn. AUD 216M of historic capital consumed across three failed or abandoned strategies. The only consistently positive operating datapoints are the 83% gross margin, the build in deferred income and the Resilient Educator contract. All are real, but small.

The August–October 2026 transactions change the risk profile more than the fundamentals. The company now has about AUD 3.3M of fresh gross capital, a refreshed board with capital-markets and digital-asset backgrounds, and a narrative (AI-assisted, sovereign-data education platform) that the market has rewarded: shares trade above the AUD 0.05 raise price, implying an estimated AUD 11–13M market capitalisation. Most of that value must be attributed to the Datasphere option and the cash. Management's own value-in-use test priced YCDI! below AUD 1.1M.

The decisive near-term question is binary and verifiable: did Datasphere exercise the Technion option before 3 October 2026, and will a definitive licence follow within the MOU timelines? Without the licence, TALi reverts to a sub-scale SEL operator whose overheads exceed its gross profit. With it, TALi becomes a long-dated deep-technology venture that will need USD 2.35M or more of further funding and specialist execution well outside its demonstrated competence.

On the evidence available, TALi is a high-risk, event-driven speculation. Monitor the September-quarter 4C, any licence announcement, and YCDI! revenue in 1HFY27 before forming a fundamental view. No rating or price target is offered.


APPENDIX A — Source reliability key

TierSourcesTreatment
Tier 1 (audited / primary)FY2025 and FY2026 Annual Reports and Appendix 4E; 1H Appendix 4D; ASX announcements (Datasphere, Notice of Meeting, AGM date); ASX Notice 0021.20.12Relied upon
Tier 2 (summaries of primary filings)Kalkine, InvestSMART, TipRanks, Stockwire X, Sharecafe and FNN summaries of Appendix 2A/3G, EGM results, 4C, SPPUsed for facts not otherwise retrieved; flagged
Tier 3 (aggregator / historical media)TipRanks financials, Stoxray, Simply Wall St, Morningstar, Market Index register, MarketBeat, Dealroom, Biotech Daily, Startup Daily, Stockhead, Motley Fool, SmallCapsFY2022–FY2023 data and pre-2019 history; flagged as unreconciled

APPENDIX B — Discrepancies noted

ItemSource ASource BTreatment
FY2025 net lossAUD -656,885 (FY25 Annual Report, original)AUD -660,624 (FY26 Annual Report, restated)Restated used in tables; original noted
FY2025 goodwillAUD 1,307,964 provisional (FY25 AR)AUD 635,260 goodwill plus AUD 856,779 other intangibles (FY26 AR restated)Restated used
FY2025 total assetsAUD 2,658,421 (FY25 AR)AUD 2,868,749 (FY26 AR restated)Restated used
FY2026 revenue headlineAUD 286,744 "revenues from ordinary activities and other income" (Appendix 4E)AUD 274,898 operating revenue (P&L note 4)Both shown; operating revenue used for margins
FY2024 revenueAUD 1,996 (TipRanks, gross service revenue)AUD -28,347 net of refunds (FY25 AR)Audited net figure used; gross noted
Employees13 (Morningstar)Not disclosed in filings; YCDI! deal included no employees—
Market capAUD 2.1M (Simply Wall St), AUD 3–4M (InvestSMART), €2.26M (Parqet)About AUD 10.8–13.5M (analyst calculation, post-Oct 2026 share count)Aggregators pre-date recapitalisation; analyst estimate used
Headquarters suburbCamberwell (Morningstar, MarketBeat)Hawthorn East (FY26 AR, Simply Wall St)FY26 AR used (current)
SPP outcomeAbout AUD 2.0M applications (Stockwire X)Quoted share count implies about 10M SPP shares (AUD 0.5M) issuedScale-back inferred, unconfirmed

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleAppointedPrior roles / experienceEducation

Dr David Brookes

Executive Chair (from 24 Mar 2026); previously NED from 29 Jun 2020 and Audit chair to 18 Oct 2022; member of Audit and Remuneration & Nomination committees

29 Jun 2020

Executive Chairman, Anatara Therapeutics (ASX: ANR). Former Chair of RHS Ltd (sold to PerkinElmer, Jun 2018). Former NE Chair, Invert Graphite (ASX: IVG); former NED, Island Pharmaceuticals (ASX: ILA).

MBBS (Adelaide), FACRRM, FAICD

Will Hamilton

Independent NED; Chair of Remuneration & Nomination Committee

24 Mar 2026

Chief Commercial Officer and GM, DigitalX Limited. Former senior roles at Animoca Brands and Trovio Group (digital asset investment). M&A/advisory at Washington H. Soul Pattinson and Ernst & Young. About 14 years' experience.

Master of Business (Finance), BSc

George Rolleston

Independent NED; Chair of Audit & Risk Committee; member of Remuneration & Nomination

16 Jun 2026

Founder and MD, Asset Growth Fund Pty Ltd and Suubee Group Pty Ltd. NED, Felix Group Holdings (ASX: FLX). Former director, MHM Automation (NZX: MHM), Feb 2019–Mar 2024.

MAPPF, B.Bus (Law)

Tim Luscombe

Company Secretary (outsourced CFO function via Bio101)

5 Dec 2022

Director of Bio101; CFO/Company Secretary for multiple ASX and private healthcare companies

BCom (Melbourne), CA, GIA(Cert)

Mark Simari

Executive Chair

NE Chair from 6 Oct 2022; Executive Chair from 16 Aug 2023; earlier director 2016–2020

Resigned 24 Mar 2026

Co-founder and former MD of Paragon Care (2008–2018); directorships at Careteq, IDT Australia, Opyl, Xpon (per FY25 report). Departure coincided with the AI-focused M&A pivot and board refresh.

Stephen Munday

Independent NED, Audit & Risk chair

18 Oct 2022 – 16 Jun 2026

Resigned 16 Jun 2026

CA, FGIA, FCG, GAICD, MBA; Careteq director. Replaced by Rolleston.

David Williams

NED

to 29 Feb 2024

Resigned

—

Dr MB Brinson

KMP (consultant)

to 11 Sep 2023

Consulting ended

Paid AUD 63,899 in FY2024

Glenn Smith

CEO (Novita era)

c.2017–2019+

—

Healthcare/recruitment background (Biotech Daily, 2018)

Directors' Remuneration

DirectorBase feesBonusSuperShare-basedTotal

Dr D Brookes

56,14106,7372,72665,604

W Hamilton (from 24 Mar 2026)

14,09500014,095

G Rolleston (from 16 Jun 2026)

1,953023402,187

M Simari (to 24 Mar 2026)

67,500005,17772,677

S Munday (to 16 Jun 2026)

50,313002,72653,039

Total

190,00206,97110,629207,602

Directors' Remuneration (Annual)

Metric (AUD)FY2024FY2025FY2026

Total KMP compensation

392,670226,136207,602

Share-based payments to KMP

98,77131,13610,629

Major Shareholders

HolderShares (pre-consolidation)% (then)

Finexia Wealth Pty Ltd (Client Nominee A/C)

477,304,48711.29

Asset Growth Fund Pty Ltd (Rolleston-associated)

201,644,0914.77

Sailors of Samui Pty Ltd

159,817,0443.78

Keiser Investments Pty Ltd (Gann Family Retirement A/C)

100,000,0002.37

Octifil Pty Ltd

98,870,1922.34

Bluewater Asset Management Pty Ltd (Teefish Super Fund A/C)

83,134,5801.97

Charkaroo Pty Ltd (Charmarbelle A/C)

77,909,0921.84

GP Securities Pty Ltd

72,571,4301.72

BNP Paribas Nominees (IB AU Noms Retailclient)

70,518,8601.67

Calama Holdings Pty Ltd (Mambat Super Fund A/C)

67,500,0001.60

Competitive Landscape

Key Competitors

CompetitorTypeMarketRelative positioning vs YCDI!

Smiling Mind

Australian not-for-profit; free mindfulness/SEL app and school programs

Australia

Free offer pressures pricing

The Resilience Project

Australian private provider of wellbeing programs and curriculum

Australia

Strong brand in Victorian schools; direct overlap

Berry Street Education Model

Not-for-profit trauma-informed PD and education model

Australia

Overlaps on PD and teacher wellbeing

Positive Education programs (e.g., Institute of Positive Education)

School-based providers

Australia

Overlap in independent schools

Second Step (Committee for Children)

US non-profit, global SEL curriculum

Global

Larger evidence base and scale

Zones of Regulation

Commercial curriculum

Global

Strong in neurodivergent/self-regulation niche

Panorama Education

US SEL survey/data platform

US

Data/analytics differentiation, which TALi now targets

Everyday Speech / Move This World

US digital SEL video curricula

US

Digital-first competitors

Kimochis and similar early-years SEL tools

Product-led early years

Global

Compete with YCDI! puppets and early-years kits

Key Competitors by Competitor Class

Competitor classExamples (publicly known)Notes

Memory majors with PIM programs

Samsung (HBM-PIM), SK hynix (AiM)

Vastly larger R&D budgets; commercial samples

Analog/in-memory AI chip start-ups

e.g., Mythic, EnCharge AI, d-Matrix

Venture-funded, pre- or early-revenue

ASX-listed neuromorphic peer

BrainChip Holdings (ASX: BRN)

Listed comparison point for investor narrative; different architecture

Competitor Detail

MetricTALi Digital (FY2026)

Revenue

AUD 0.27M

Revenue growth

n.m. (acquisition-driven)

Gross margin

83.0%

EBITDA margin (underlying)

-344%

Company Snapshot

13

Employees

2004

Founded

Hawthorn East, Australia

Headquarters

SWOT Analysis

Strengths

  • High gross margin: FY2026 gross profit AUD 228,160 on revenue AUD 274,898 (83.0%) (FY26 Annual Report).
  • Recurring revenue base: subscriptions were 70.6% of FY2026 revenue, recognised over time (note 4).
  • Billings ahead of revenue: deferred income rose AUD 185,967 to AUD 189,499 (FY26 Appendix 4E).
  • Debt-free balance sheet: no borrowings since AUD 503,744 was repaid in FY2024 (FY25 cash flow statement).
  • Demonstrated access to capital: SPP about 4x oversubscribed (about AUD 2.0M against AUD 0.5M); EGM resolutions passed with up to 99.80% support (25 Sep 2026).
  • Brand credentials: YCDI! reached over one million students; ACARA-aligned; Be You recognised (FY26 Annual Report).

Weaknesses

  • Sub-scale revenue: AUD 274,898 against AUD 2.67M of total expenses (FY2026).
  • Acquisition write-off: the YCDI! CGU, bought for AUD 1.34M in June 2025, was fully impaired by AUD 1.34M at 30 June 2026 (note 12).
  • Rising cash burn: operating outflow rose from AUD 472,806 (FY2025) to AUD 737,321 (FY2026).
  • Thin management bench: no CEO or CFO; finance outsourced (Bio101); three-person board refreshed in 2026 (FY26 Annual Report).
  • Legacy value destruction: accumulated losses AUD 215.8M; TALi intangibles of AUD 4.19M impaired in FY2024 (FY25 Annual Report).
  • Shareholder value: FY-end share price AUD 0.032 (FY2021) to AUD 0.001 (FY2025) pre-consolidation, about -97% (FY25 TSR table).

Opportunities

  • Resilient Educator potential revenue over AUD 0.5M by end-2027, scaling from 60 to over 400 teachers across over 250 schools (23 Jul 2026), with stated intent to replicate in other states.
  • Product pipeline: Neurodivergent Learning Strategies, AI for Educators, 21-Day Reset, MHFA instructor certification from Q4 CY2026 (FY26 Annual Report).
  • International demand: interest from Estonia, Romania, Saudi Arabia, NZ, Japan; NZ, Europe and RoW already 16.4% of FY2026 revenue (note 4).
  • Technion licence: exclusive worldwide sublicensable rights with a 2% royalty structure, if executed (Datasphere announcement).
  • Funded runway: about AUD 3.3M gross raised in Aug–Oct 2026 versus FY2026 operating burn of AUD 0.74M.
  • Tax losses: about AUD 168M of unused losses (unrecognised) could shelter future profits, subject to continuity-of-ownership and similar-business tests (FY26 note 6).

Threats

  • Licence non-execution: the option expired 3 Oct 2026 unless exercised, and the MOU terminates if no licence is signed within 180 days of exercise (Datasphere announcement).
  • Follow-on capital demands: USD 1.0M (18 months) and USD 1.35M (36 months) conditions subsequent, plus about NIS 579k of patent-cost reimbursements.
  • Dilution overhang: about 21.5M AUD 0.15 options (to 2031), 1.25M AUD 0.10 options, 1.21M other options (Appendix 2A, 1 Oct 2026).
  • Revenue diversion risk: the FY2026 risk section explicitly flags previous owners potentially leveraging relationships or confidential information.
  • Cyber and privacy obligations: the company plans to hold child cognitive and mental-health data; breaches would be existential.
  • Competitive pricing pressure: free and NFP SEL programs (e.g., Smiling Mind); policy-driven funding shifts (FY25 risk section).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
20 Mar 2025Partner Vertical 4 (formerly Genius Learning) enters voluntary administrationLegacy TALi distribution collapses; product rights in limbo (just before window, included for context)
Apr–May 2025Trading halt; YCDI! acquisition and equity raising announcedStrategic pivot to education
12 Jun 2025YCDI Education Australia Pty Ltd established; control gainedNew operating subsidiary
18 Jun 2025YCDI! business acquired for AUD 1.34MFirst revenue-generating asset since outsourcing
19 Jun 2025800M shares placed at AUD 0.001 (AUD 0.8M)Funds acquisition
8–11 Jul 20251-for-6 entitlement offer closes, about AUD 131k raised; shortfall reservedLimited retail support
Jul 2025June-quarter 4CLow burn (about AUD 0.1M per quarter)
3 Aug 202515M AUD 0.03 options lapseCapital structure tidy-up
14 Aug 2025FY2025 results: loss AUD 0.66M, cash AUD 1.29MShell-like year closes
Sep–Oct 2025Placement of entitlement shortfall (about 446M pre-consolidation shares)Further equity
31 Oct 2025Notice of AGM; consolidation proposal—
11 Nov 2025AGM approves 100:1 consolidation; FinCap options approvedShare structure normalised
27 Nov 2025Consolidated securities; unquoted securities notifications—
Jan 2026December-quarter 4C and YCDI! update: CANVAS migration, website, school engagement, new programsOperational foundation for 2026 school year
19 Feb 20261HFY26 Appendix 4D: revenue AUD 72.8k (+98%), loss AUD 571kFirst half under YCDI!
19 Feb 20261HFY26 highlights and 2026 priorities; share price +57% intradayMarket re-rating from AUD 0.051
24 Mar 2026Simari resigns; Brookes becomes Executive Chair; Hamilton appointedLeadership change toward AI/deal orientation
Apr 2026March-quarter 4C—
May 2026Remuneration & Nomination Committee re-formedGovernance
25–26 May 2026360,000 executive director options lapse; cessation noticeSimari options lapse
16 Jun 2026Munday resigns; Rolleston appointed (Audit & Risk chair)Board fully refreshed, except Brookes
16 Jul 2026180,000 options lapse—
23 Jul 2026Resilient Educator Partnership announced (14 months, Victoria)First quantified contract opportunity (over AUD 0.5M potential)
30 Jul 2026June-quarter 4C: cash about AUD 1.0M, net outflow about AUD 0.1M; AI M&A under reviewStable burn
21 Aug 2026Datasphere share sale agreement executed—
24 Aug 2026Datasphere acquisition and AUD 3.3M raise announced; trading halt liftedMajor strategic and capital event
26 Aug 2026Tranche 1 placement (7.0M shares, about AUD 350k) issued; FY2026 results with AUD 1.34M impairmentImpairment of 2025 acquisition
27 Aug 2026Notice of General Meeting dispatched—
28 Aug–1 Sep 2026SPP prospectus lodged—
17 Sep 2026AGM date set (26 Nov 2026); director nominations close 8 Oct 2026—
22–25 Sep 2026SPP closes about 4x oversubscribed (about AUD 2.0M applications)Strong retail demand
25 Sep 2026EGM passes all 10 resolutions (consideration shares 99.80% for; placement options 98.99%)Transaction approved
29 Sep 202618,199,976 AUD 0.15 options (expiring 29 Sep 2031) issuedOverhang created
1 Oct 202622M consideration shares and Tranche 2 balance issued; quoted shares reach 112,727,470; 466,666 delayed-settlement options issuedDatasphere completion
3 Oct 2026Technion option-period expiry date. Exercise and qualifying financing not confirmed in sources reviewed.Key binary milestone. Monitor for announcement.

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

3 charts
Income Statement (AUD): Operating revenue to Depreciation and amortisation: Operating revenue rose from AUD 13,165 in FY2022 to AUD 274,898 in FY2026.
Tali Digital Ltd — Income Statement (AUD): Operating revenue to Depreciation and amortisation
Series (AUD)FY2022FY2023FY2024FY2025FY2026
Operating revenue13,16526,627-28,3471,186274,898
Revenue and other income incl. interest——231,72155,591286,744
Cost of sales——00-46,738
Gross profit——-28,3471,186228,160
Net impairment——-2,144,1020-1,335,237
Depreciation and amortisation-371,380-319,750-178,198-5,155-156,802

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.